# Real-world Study on the Management of Hematological Toxicities Associated With Targeted Therapies for Breast Cancer

> **NCT06503380** · — · RECRUITING · sponsor: **Fudan University** · enrollment: 1000 (estimated)

## Conditions studied

- Hematological Toxicity
- Targeted Therapy
- Breast Cancer

## Interventions

- **OTHER:** No intervenrion.

## Key facts

- **NCT ID:** NCT06503380
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-15
- **Primary completion:** 2026-07-15
- **Final completion:** 2027-06-10
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2024-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06503380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06503380, "Real-world Study on the Management of Hematological Toxicities Associated With Targeted Therapies for Breast Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06503380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*